Tuesday, May 21, 2013

Company announcements: NH Ceram, Religare

NH Ceram - MISCELLANEOUS :: PROPOSED SALE OF PROPERTIES - SIGNING OF MEMORANDUM OF AGREEMENT

Announcement Type: MISCELLANEOUS
Company: NH CERAMICS LTD
Stock Code/Name: 5AC - NH Ceram

MISCELLANEOUS
* Asterisks denote mandatory information
Name of Announcer * NH CERAMICS LTD  
Company Registration No. 199704544C  
Announcement submitted on behalf of NH CERAMICS LTD  
Announcement is submitted with respect to * NH CERAMICS LTD  
Announcement is submitted by * ROBERT GUNTHER MEYER  
Designation * EXECUTIVE CHAIRMAN  
Date & Time of Broadcast 21-May-2013 22:32:53  
Announcement No. 00150  
>> ANNOUNCEMENT DETAILS
The details of the announcement start here ...
Announcement Title * PROPOSED SALE OF PROPERTIES - SIGNING OF MEMORANDUM OF AGREEMENT  
Description
   
Attachments
Total size = 131K
(2048K size limit recommended)


Religare - ANNOUNCEMENT OF APPOINTMENT OF CHIEF EXECUTIVE OFFICER

Announcement Type: ANNOUNCEMENT OF APPOINTMENT
Company: RELIGARE HEALTH TRUST
Stock Code/Name: RF1U - Religare

ANNOUNCEMENT OF APPOINTMENT OF CHIEF EXECUTIVE OFFICER *
* Asterisks denote mandatory information
Name of Announcer * RELIGARE HEALTH TRUST  
Company Registration No. N.A.  
Announcement submitted on behalf of RELIGARE HEALTH TRUST  
Announcement is submitted with respect to * RELIGARE HEALTH TRUST  
Announcement is submitted by * Ravi Mehrotra  
Designation * Executive Chairman and Director  
Date & Time of Broadcast 21-May-2013 21:53:45  
Announcement No. 00143  
>> ANNOUNCEMENT DETAILS
The details of the announcement start here ...
Date of Appointment * 22-05-2013  
Name of Person* Gurpreet Singh Dhillon  
Age * 29  
Country of principal residence * Singapore  
The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process) * The Nominating Committee had reviewed and assessed Mr Gurpreet Singh Dhillon's qualifications and his work experience. Based on Mr Gurpreet Singh Dhillon's past track record and credentials, the Nominating Committee is of the view that he will be able to add value to Religare Health Trust Trustee Manager Pte. Ltd. ('RHTTM') as the Chief Executive Officer.  
Whether appointment is executive, and if so, the area of responsibility *
Executive.

Mr Gurpreet Singh Dhillon is responsible in managing the daily operations relating to RHTTM and Religare Health Trust.
 
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) Executive Director and Chief Executive Officer  
Working experience and occupation(s) during the past 10 years *
Mr Gurpreet Dhillon is a founding shareholder of Religare Enterprises Ltd ('REL'), the listed entity that holds RHTTM. Since being set up in 2001, REL has grown to become one of India’s largest Financial Services groups with a leading presence in sectors Broking, Insurance, Lending and asset management. He has been instrumental in helping REL build its investment banking and asset management ventures in emerging markets.

From 2005 to 2011, Mr Dhillon was on the Board of Directors of Religare Capital Markets Plc, the investment banking arm of REL which focuses on emerging markets. Prior to his appointment as CEO, Mr Dhillon was COO of RHTTM, where his responsibilities included overseeing operations and investments of RHT.

Mr Dhillon has deep corporate finance and real estate experience, having worked on a number of Indian real estate transactions.  
Interest * in the listed issuer and its subsidiaries *
1,237,000 Common Units (0.16% based on total issued units of 788,131,944 units in Religare Health Trust)  
Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries *
Mr Gurpreet Singh Dhillon is a second cousin of Mr Malvinder Mohan Singh and Mr Shivinder Mohan Singh, who are indirect substantial unitholders of Religare Health Trust  
Conflict of interests (including any competing business) *
None  
>> OTHER DIRECTORSHIP#
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704(9) or Catalist Rule 704(8).
Past (for the last 5 years)
ARM Corporate Finance Limited
Blomfield Capital Limited
Blomfield Investment Management Limited
Charterpace Limited
Claridge House Services Limited
Religare Hichens Harrison Consultoria Internacional Ltd
HH1803.Com Limited
Hichens, Harrison (Commodities) Limited
Hichens, Harrison (Derivatives) LLP
Hichens, Harrison (Middle East) Limited
Hichens, Harrison (North America) Limited
Hichens, Harrison (Ventures) Limited
London Wall Nominees Limited
Medserve (ME) Limited
Religare Capital Markets Corporate Finance Pte. Ltd.
Religare Capital Markets (Europe) Limited (formerly known as Religare Capital Markets Plc)
Tobler UK Limited
 
Present
Fortis Global Healthcare Infrastructure Pte. Ltd.
One and Only Holdings Pte. Limited
Religare Global Asset Management Singapore Pte. Ltd.
Vistaar Religare Capital Advisers Limited
 
>> INFORMATION REQUIRED PERSUANT TO LISTING RULE 704(7)(H)

Disclose the following matters concerning an appointment of director, chief executive officer, general manager or other executive officer of equivalent rank. If the answer to any questions is "yes", full details must be given.

(a)*Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
  • No  

       


    • Religare - ANNOUNCEMENT OF CESSATION AS CHIEF EXECUTIVE OFFICER

    Announcement Type: ANNOUNCEMENT OF CESSATION
    Company: RELIGARE HEALTH TRUST
    Stock Code/Name: RF1U - Religare

    ANNOUNCEMENT OF CESSATION AS CHIEF EXECUTIVE OFFICER *
    * Asterisks denote mandatory information
    Name of Announcer * RELIGARE HEALTH TRUST  
    Company Registration No. N.A.  
    Announcement submitted on behalf of RELIGARE HEALTH TRUST  
    Announcement is submitted with respect to * RELIGARE HEALTH TRUST  
    Announcement is submitted by * Gurpreet Singh Dhillon  
    Designation * Executive Director  
    Date & Time of Broadcast 21-May-2013 21:50:13  
    Announcement No. 00142  
    >> ANNOUNCEMENT DETAILS
    The details of the announcement start here ...
    Name of person * Ravi Mehrotra  
    Age * 52  
    Is Effective Date of Cessation known? * Yes  
    If yes, please provide the date * 22-05-2013  
    Detailed Reason(s) for cessation *
    To separate the roles of the Chairman and Chief Executive Officer.  
    Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting? * No 
    If yes, please elaborate * NA 
    Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer? * No 
    If yes, please elaborate * NA 
    Any other relevant information to be provided to shareholders of the listed issuer? * No 
    If yes, please elaborate * NA 
    Date of Appointment to current position * 07-09-2012  
    Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) * Executive Chairman and Chief Executive Officer  
    Role and responsibilities *
    Managing the daily operations relating to Religare Health Trust Trustee Manager Pte. Ltd. and Religare Health Trust.  
    Does the AC have a minimum of 3 members (taking into account this cessation)? *Yes 
    Number of Independent Directors currently resident in Singapore (taking into account this cessation) *2 
    Number of cessations of appointments specified in Listing Rule 704(7) or Catalist Rule 704(6) over the past 12 months *0 
    Interest * in the listed issuer and its subsidiaries *
    1,000,000 Common Units (0.13% based on total issued units of 788,131,944 units in Religare Health Trust)  
    Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries *
    NA  
    >> OTHER DIRECTORSHIPS
    Past (for the last 5 years) *
    AIG Capital India Private Limited
    AIG Global Asset Management Company (India) Pvt Ltd
    Huatai-PineBridge Fund Management Company Limited
    Philam Asset Management Inc.
    PineBridge Investments Asia Limited
    PineBridge Investments East Africa Limited
    PineBridge Investments Hong Kong Limited
    PineBridge Investments Management Taiwan Limited
    PineBridge Investments Singapore Limited
    Ranbaxy Laboratories Limited  
    Present *
    Fortis Global Healthcare Infrastructure Pte. Ltd.
    AEGON Religare Life Insurance Company Limited
    Landmark Partners LLC
    Northgate Capital LLC
    Religare Capital Markets Limited
    Religare Enterprises Limited
    Religare Global Asset Management Inc.
    Religare Global Asset Management Japan Co. Limited
    Religare Global Asset Management Singapore Pte. Ltd.
    Religare Health Insurance Company Limited  
    Footnotes
    Nomura Singapore Limited, Religare Capital Markets Corporate Finance Pte. Limited and Standard Chartered Securities (Singapore) Pte. Limited (“Standard Chartered Securities”) were the joint issue managers (“Joint Issue Managers”) of the Offering. CIMB Securities (Singapore) Pte. Ltd., DBS Bank Ltd., Nomura Securities Singapore Pte. Ltd., Religare Capital Markets (Singapore) Pte. Limited and Standard Chartered Securities were the joint global coordinators, bookrunners and underwriters ("Joint Bookrunners") of the Offering. The Joint Issue Managers and the Joint Bookrunners assume no responsibility for the contents of this announcement.  
    Attachments
    Total size = 0
    (2048K size limit recommended)


    Religare - MISCELLANEOUS

    Announcement Type: MISCELLANEOUS
    Company: RELIGARE HEALTH TRUST
    Stock Code/Name: RF1U - Religare

    MISCELLANEOUS
    * Asterisks denote mandatory information
    Name of Announcer * RELIGARE HEALTH TRUST  
    Company Registration No. N.A.  
    Announcement submitted on behalf of RELIGARE HEALTH TRUST  
    Announcement is submitted with respect to * RELIGARE HEALTH TRUST  
    Announcement is submitted by * Gurpreet Singh Dhillon  
    Designation * Chief Executive Officer and Executive Director  
    Date & Time of Broadcast 21-May-2013 22:43:39  
    Announcement No. 00152  
    >> ANNOUNCEMENT DETAILS
    The details of the announcement start here ...
    Announcement Title * Press Release - Religare Health Trust Announces Its Full Year Results and DPU of 3.55 cents Representing Yield of 8.75%  
    Description
    Please see attached.

    Nomura Singapore Limited, Religare Capital Markets Corporate Finance Pte. Limited and Standard Chartered Securities (Singapore) Pte. Limited (“Standard Chartered Securities”) were the joint issue managers (“Joint Issue Managers”) of the Offering. CIMB Securities (Singapore) Pte. Ltd., DBS Bank Ltd., Nomura Securities Singapore Pte. Ltd., Religare Capital Markets (Singapore) Pte. Limited and Standard Chartered Securities were the joint global coordinators, bookrunners and underwriters ("Joint Bookrunners") of the Offering. The Joint Issue Managers and the Joint Bookrunners assume no responsibility for the contents of this announcement.  
    Attachments
    Total size = 151K
    (2048K size limit recommended)


    Religare - FULL YEAR RESULTS * FINANCIAL STATEMENT AND RELATED ANNOUNCEMENT

    Announcement Type: FINANCIAL STATEMENT AND RELATED ANNOUNCEMENT
    Company: RELIGARE HEALTH TRUST
    Stock Code/Name: RF1U - Religare

    FULL YEAR RESULTS * FINANCIAL STATEMENT AND RELATED ANNOUNCEMENT
    * Asterisks denote mandatory information
    Name of Announcer * RELIGARE HEALTH TRUST  
    Company Registration No. N.A.  
    Announcement submitted on behalf of RELIGARE HEALTH TRUST  
    Announcement is submitted with respect to * RELIGARE HEALTH TRUST  
    Announcement is submitted by * Gurpreet Singh Dhillon  
    Designation * Chief Executive Officer and Executive Director  
    Date & Time of Broadcast 21-May-2013 22:35:05  
    Announcement No. 00151  
    >> ANNOUNCEMENT DETAILS
    The details of the announcement start here ...
    For the Financial Period Ended * 31-03-2013  
    DescriptionPlease see attached.

    Nomura Singapore Limited, Religare Capital Markets Corporate Finance Pte. Limited and Standard Chartered Securities (Singapore) Pte. Limited (“Standard Chartered Securities”) were the joint issue managers (“Joint Issue Managers”) of the Offering. CIMB Securities (Singapore) Pte. Ltd., DBS Bank Ltd., Nomura Securities Singapore Pte. Ltd., Religare Capital Markets (Singapore) Pte. Limited and Standard Chartered Securities were the joint global coordinators, bookrunners and underwriters ("Joint Bookrunners") of the Offering. The Joint Issue Managers and the Joint Bookrunners assume no responsibility for the contents of this announcement.  
    Attachments
    Total size = 321K
    (2048K size limit recommended)


    Labels: ,

    No comments:

    Post a Comment

    Subscribe to: Post Comments (Atom)